↓ Skip to main content

Efficacy and Safety of Valproic Acid for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis

Overview of attention for article published in CNS Drugs, February 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
61 Mendeley
Title
Efficacy and Safety of Valproic Acid for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis
Published in
CNS Drugs, February 2019
DOI 10.1007/s40263-019-00606-6
Pubmed ID
Authors

Abdelrahman Elshafay, Truong Hong Hieu, Mohamed Fahmy Doheim, Mahmoud Attia Mohamed Kassem, Mohammed Fathi ELdoadoa, Sarah Keturah Holloway, Heba Abo-elghar, Kenji Hirayama, Nguyen Tien Huy

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 61 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 13%
Student > Bachelor 7 11%
Student > Ph. D. Student 6 10%
Researcher 5 8%
Other 3 5%
Other 9 15%
Unknown 23 38%
Readers by discipline Count As %
Medicine and Dentistry 12 20%
Biochemistry, Genetics and Molecular Biology 5 8%
Nursing and Health Professions 5 8%
Neuroscience 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Other 8 13%
Unknown 24 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2023.
All research outputs
#7,073,340
of 23,136,540 outputs
Outputs from CNS Drugs
#643
of 1,319 outputs
Outputs of similar age
#133,438
of 352,998 outputs
Outputs of similar age from CNS Drugs
#12
of 20 outputs
Altmetric has tracked 23,136,540 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,319 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,998 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.